Monsanto Co (MON):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Monsanto Co (MON) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12357
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Monsanto Company (Monsanto) is an agricultural products manufacturing company. It develops and delivers agricultural products to support farmers all around the world. The company develops biotechnology traits that assist farmers in controlling insects and weeds. It also provides other seed companies with genetic material and biotechnology traits for their seed brands. The product line of the company includes agricultural and vegetable seeds, plant biotechnology traits and crop protection chemicals. The company operates in North America, South America, Europe, Asia, Australia and Africa; and has worldwide distribution, and sales and marketing network for its seeds and traits. Monsanto is headquartered in St. Louis, Missouri, the US.

Monsanto Co (MON) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Monsanto Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Monsanto Co, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Monsanto Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Monsanto Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Monsanto Co, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Monsanto Co, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
RaNA Therapeutics Raises Additional US$18 Million In Series A Financing 10
Licensing Agreements 12
Tekmira Enters Into Option For Licensing Agreement With Monsanto 12
Acquisition 13
Monsanto Invests In Synthetic Genomics, Developer Of Genomic-Driven Solutions 13
Monsanto Co – Key Competitors 14
Monsanto Co – Key Employees 15
Monsanto Co – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Monsanto Co, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Monsanto Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Monsanto Co, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Monsanto Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Monsanto Co, Deals By Therapy Area, 2012 to YTD 2018 8
Monsanto Co, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
RaNA Therapeutics Raises Additional US$18 Million In Series A Financing 10
Tekmira Enters Into Option For Licensing Agreement With Monsanto 12
Monsanto Invests In Synthetic Genomics, Developer Of Genomic-Driven Solutions 13
Monsanto Co, Key Competitors 14
Monsanto Co, Key Employees 15
Monsanto Co, Other Locations 16
Monsanto Co, Subsidiaries 17

List of Figures
Monsanto Co, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Monsanto Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Monsanto Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Monsanto Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Monsanto Co, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Monsanto Co, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Monsanto Co, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Monsanto Co, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Monsanto Co (MON):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Palatin Technologies Inc (PTN):製薬・医療:M&Aディール及び事業提携情報
    Summary Palatin Technologies Inc (Palatin) is a biopharmaceutical company that undertakes the development of targeted, receptor-specific peptide therapeutics. The company’s development programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor sys …
  • Natrix Separations Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Natrix Separations Inc (Natrix), formerly Nysa Membrane Technologies, a subsidiary of Merck KGaA, is a supplier of single use and multi-cycle disposable chromatography products. The company offers NatriFlo HD-Q membrane adsorbers, an advanced material with a three-dimensional macroporous hyd …
  • Japan Petroleum Exploration Co Ltd (1662):石油・ガス:M&Aディール及び事業提携情報
    Summary Japan Petroleum Exploration Co Ltd (JAPEX) is an oil and gas company that offers exploration, development, production, and sales of oil, natural gas, and other energy resources. The company’s services include acquisition of blocks, development, exploration, supplying, selling, and transporta …
  • Eisai Inc:企業の戦略的SWOT分析
    Eisai Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • GAIL (India) Ltd (GAIL)-エネルギー分野:企業M&A・提携分析
    Summary GAIL (India) Ltd (GAIL) is a vertically integrated gas company that carries out exploration and production, transmission of natural gas. It also has presence in petrochemical, liquid hydrocarbons and power and renewable sectors. GAIL is also a major LPG transmission company, besides managing …
  • Nestle USA, Inc.:企業の戦略・SWOT・財務情報
    Nestle USA, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nestle USA, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Petrobras Argentina SA:石油・ガス:M&Aディール及び事業提携情報
    Summary Petrobras Argentina SA (PESA), a subsidiary of Pampa Energia S.A, is an integrated energy company. It carries out the exploration and production of crude oil and natural gas, refining of crude oil, transportation, and marketing of oil and refined products. The company’s product portfolio inc …
  • Damac Real Estate Development Ltd:企業の戦略・SWOT・財務分析
    Damac Real Estate Development Ltd - Strategy, SWOT and Corporate Finance Report Summary Damac Real Estate Development Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Marco’s Franchising, LLC:企業の戦略・SWOT・財務情報
    Marco's Franchising, LLC - Strategy, SWOT and Corporate Finance Report Summary Marco's Franchising, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Phosplatin Therapeutics LLC-製薬・医療分野:企業M&A・提携分析
    Summary Phosplatin Therapeutics LLC (Phosplatin Therapeutics) is a drug development company that carries out the clinical development of phosphaplatins products. The company develops small-molecule compounds which are used for the treatment of cancer. It has collaborations with various contract rese …
  • Allan Myers Inc:企業の戦略・SWOT・財務分析
    Allan Myers Inc - Strategy, SWOT and Corporate Finance Report Summary Allan Myers Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • GKE Corporation Limited (595):企業の財務・戦略的SWOT分析
    GKE Corporation Limited (595) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Acino International AG:企業の戦略的SWOT分析
    Acino International AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Alphatec Holdings Inc (ATEC):医療機器:M&Aディール及び事業提携情報
    Summary Alphatec Holdings Inc (Alphatec) is a medical technology company that focuses on the design, development and marketing of spinal fusion technology products and solutions for the treatment of spine disorders. The company’s major products include anterior cervical plate system, posterior cervi …
  • Tibet Rhodiola Pharmaceutical Holding Co Ltd (600211):企業の財務・戦略的SWOT分析
    Summary Tibet Rhodiola Pharmaceutical Holding Co Ltd (TRPHC) is a pharmaceutical company that manufactures and markets Chinese medicine. The company’s products include children shuangqing particles, little dragon capsule, nuodikang capsule, shuxioang capsules, snowy jin luohan analgesic balm, pu yu …
  • Rothschild Bank AG:企業の戦略・SWOT・財務情報
    Rothschild Bank AG - Strategy, SWOT and Corporate Finance Report Summary Rothschild Bank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • ASIT Biotech SA (ASIT):企業の財務・戦略的SWOT分析
    Summary ASIT Biotech SA (ASIT Biotech), formerly BioTech Tools SA is a clinical stage biopharmaceutical company that develops in-vitro and in-vivo biotech tools. The company develops and commercializes immunotherapy medicines for respiratory and food allergies using ASIT plus technology platform. It …
  • Alnylam Pharmaceuticals Inc (ALNY)-医療機器分野:企業M&A・提携分析
    Summary Alnylam Pharmaceuticals Inc, (Alnylam) is a biopharmaceutical company which discovers, develops and commercializes therapeutics based on Ribo Nucleic Acid interference (RNAi). The company offers a broad pipeline of investigational RNAi therapeutics in the areas of genetic medicines; cardiova …
  • Quantum Fuel Systems LLC:企業の戦略的SWOT分析
    Quantum Fuel Systems LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • DHX Media Ltd.:企業のM&A・事業提携・投資動向
    DHX Media Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DHX Media Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆